Frontier Advisory Partners

Mandate

Dei BioPharma

Feasibility study and Business Plan for a $1b-dollar pharmaceutical manufacturing plant.

Service
Corporate Finance
Sector
Health & Life Sciences
Year
2024/2025

Talk to the team behind this work.

Contact Us